Lifecore Biomedical (LFCR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Meeting called to order with a quorum present and polls opened for voting.
Inspector of Elections appointed and sworn in; meeting rules and agenda displayed to participants.
Attendees included executive officers and the independent auditor, available for questions.
Shareholder proposals
Four proposals presented: election of directors, ratification of KPMG LLP as auditor, advisory vote on executive compensation, and approval of the 2026 Stock Incentive Plan.
Voting rights for common and Series A preferred stockholders clarified, with both groups voting together on most matters.
Board unanimously recommended approval of all four proposals.
No questions were submitted by shareholders regarding the proposals.
Board and executive committee updates
Nine director nominees listed, with two elected solely by Series A Preferred holders and seven by all voting stockholders.
Each director to serve until the next annual meeting or until a successor is elected.
Latest events from Lifecore Biomedical
- Proxy seeks approval for director elections, auditor ratification, say-on-pay, and a new stock plan.LFCR
Proxy filing18 May 2026 - Shareholders will vote on board declassification, director elections, compensation, and share increases.LFCR
Proxy filing18 May 2026 - Shareholders will vote on board declassification, director elections, compensation, and capital structure changes.LFCR
Proxy filing18 May 2026 - Voting standards and amendment language clarified for share increase proposal at August 2024 meeting.LFCR
Proxy filing18 May 2026 - Q3 revenue up 35% year-over-year with net income of $15.6M, but internal control and compliance risks remain.LFCR
Q3 202418 May 2026 - Q2 revenue up 38% to $30.2M, net income $14.2M, with improved margins and ongoing risk remediation.LFCR
Q2 202418 May 2026 - Proxy seeks votes on directors, auditor, and executive pay, highlighting governance and board changes.LFCR
Proxy filing18 May 2026 - Up to 6.8 million shares registered for resale; no proceeds to company; dilution and governance impact.LFCR
Registration filing18 May 2026 - Stockholders will vote to remove the cap on Series A Preferred Stock conversion, impacting share count.LFCR
Proxy filing18 May 2026